Pharmaceutical Archives

Optalert Pushes Further into Medtech, Appointing Experienced Technology Commercialisation Specialist, Christine Cussen to its Board.

Tuesday, 14 September 2021 Optalert, the world’s leader in drowsiness and alertness detection, today appointed Non-executive Director Ms Christine Cussen to its board. Ms Cussen has a long and distinguished career with decades of executive and board experience across diverse industry sectors in listed, private and government sectors including global pharmaceutical, biotechnology, medical, industrial, and …

Optalert Pushes Further into Medtech, Appointing Experienced Technology Commercialisation Specialist, Christine Cussen to its Board. Read More »

Global Neurology Expert Joins the Board of World’s Leading Drowsiness & Alertness Detection Company, Optalert

Automotive, Goods & Passenger Transport, Mining, Neurology, Pharmaceutical / By optalert

Optalert, the world’s leader in drowsiness and alertness detection, today welcomed Professor Matthew Kiernan as a new Non- Executive Director of its board. Professor Matthew Kiernan is Co-Director of the Brain and Mind Centre, focusing on discovery and translation and President of the Brain Foundation, funding world-class research into neurological disorders, brain disease and brain injuries. He …

Global Neurology Expert Joins the Board of World’s Leading Drowsiness & Alertness Detection Company, Optalert Read More »

Safely navigating through a crisis

Automotive, Goods & Passenger Transport, Mining, Neurology, Pharmaceutical / By optalert

2020 will go down as one of the most difficult for companies and leaders around the world. The corona virus has taken lives, isolated families, closed airports and put a fear into many like never before. Whilst most of us have had the privilege of a stable life occupied with routine, the future is now …

Safely navigating through a crisis Read More »

What is the Optalert JDS™ and why is it leading the drowsiness monitoring field?

Pharmaceutical / By optalert

Optalert’s sophisticated software algorithm, leads the drowsiness monitoring field, by providing the next level layer within driver monitoring systems (DMS). Optalert’s scientifically validated Johns Drowsiness Scale (JDSTM) enables an objective, real time, quantifiable measure of drowsiness. Applicable across ethnicity, gender and age, the JDS™ empowers the driver with the ability to avoid dangerous microsleeps. Providing …

What is the Optalert JDS™ and why is it leading the drowsiness monitoring field? Read More »

Could blinks be the answer to Alzheimer’s disease?

Neurology, Pharmaceutical / By optalert

September is World Alzheimer’s month, the international campaign which raises awareness and challenges the stigma that surrounds dementia. Around the world 50 million people have dementia, and each year there are nearly 10 million new cases. The total number of people with dementia is projected to reach 82 million by 2030! With over 100 forms …

Could blinks be the answer to Alzheimer’s disease? Read More »

BIO2019 Philadelphia – It Starts with One!

Pharmaceutical / By optalert

BIO International Convention is back in Philadelphia, June 3-6, to celebrate the globally important innovations in biotech that start with one: one meeting, one theory, one trial, one breakthrough. Optalert look forward to joining the global biotech community during partnering sessions and will be available for meetings through the official Bio2019 partnering portal, opening …

BIO2019 Philadelphia – It Starts with One! Read More »

Las Vegas CES2019 Highlights

Automotive, Pharmaceutical / By optalert

The Consumer Electronics Show (CES2019) dazzled participants once again with glimpses of technologies and products on the horizon for the future. With over 180,000 attendees from 150 different countries, circulating over 11 venues throughout Las Vegas. Optalert’s key conversations at this year’s event included autonomous vehicles, enhanced ‘early warning’ drowsiness and distraction features, and AI …

Las Vegas CES2019 Highlights Read More »

Introducing the BlinQ system by Optalert

Pharmaceutical / By optalert

Optalert is pleased to introduce the BlinQ system for the measurement of drowsiness or wakefulness in clinical trials. Optalert uses advanced patented algorithms to determine the exact drowsiness or wakefulness of a subject. By applying Artificial Intelligence techniques and machine learning Optalert has been able to objectively quantify drowsiness or wakefulness. Utilising the Johns Drowsiness Scale (JDS), Optalert’s future-proofed …

Introducing the BlinQ system by Optalert Read More »

Challenges of pharmaceutical companies

Pharmaceutical / By optalert

Pharmaceutical companies face many challenges, with hundreds of new drugs required to transition through clinical trial phases, regulatory processes and to market, more quickly and more efficiently. The Centre for the Study of Drug Development (CSDD) estimates the cost of developing a prescription drug that gains market approval at $2.6 billion. Even more remarkable is …

Challenges of pharmaceutical companies Read More »

5 of the greatest technological discoveries in the medical field

Pharmaceutical / By optalert

Every technological discovery aims to improve our health, safety, and quality of life. Every day, we marvel over exciting new developments that emerge from each corner of the globe. A few weeks ago, we looked at seven of the most significant pharmacological discoveries, and this week, we want to expand our exploration into great technology …

5 of the greatest technological discoveries in the medical field Read More »

Pharmaceutical

Subscribe to our mailing list to stay informed of our major announcements